0.84Open0.84Pre Close0 Volume1 Open Interest30.00Strike Price0.00Turnover401.64%IV54.51%PremiumNov 8, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.84Extrinsic Value100Contract SizeAmericanOptions Type0.2160Delta0.0357Gamma23.76Leverage Ratio-0.3139Theta0.0004Rho5.13Eff Leverage0.0060Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet